Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-05-18 4:30 pm Purchase |
2021-05-17 | 13G | Forte Biosciences, Inc. FBRX |
Point72 Asset Management, L.P. | 27,842 5.200% |
27,842 (New Position) |
Filing History |
| 2021-05-13 4:34 pm Purchase |
2021-05-04 | 13G | Global Blood Therapeutics, Inc. GBT |
Point72 Asset Management, L.P. | 3,224,574 5.200% |
2,797,541 (+655.11%) |
Filing History |
| 2021-04-01 4:57 pm Purchase |
2021-03-31 | 13G | Kindred Biosciences, Inc. KIN |
Point72 Asset Management, L.P. | 3,858,103 8.700% |
3,858,103 (New Position) |
Filing History |
| 2021-03-24 5:25 pm Purchase |
2021-03-23 | 13G | TRICIDA INC TCDAQ |
Point72 Asset Management, L.P. | 2,525,538 5.000% |
2,525,538 (New Position) |
Filing History |
| 2021-03-22 5:03 pm Purchase |
2021-03-12 | 13G | Curis, Inc. CRIS |
Point72 Asset Management, L.P. | 266,997 5.800% |
266,997 (New Position) |
Filing History |
| 2021-03-22 5:02 pm Purchase |
2021-03-16 | 13G | Prometheus Biosciences, Inc. RXDX |
Point72 Asset Management, L.P. | 2,648,024 6.800% |
2,648,024 (New Position) |
Filing History |
| 2021-03-02 5:04 pm Purchase |
2021-03-01 | 13G | Paya Holdings Inc. PAYA |
Point72 Asset Management, L.P. | 6,459,793 5.500% |
6,459,793 (New Position) |
Filing History |
| 2021-03-01 5:19 pm Purchase |
2021-02-17 | 13G | Mereo BioPharma Group plc MREO |
Point72 Asset Management, L.P. | 6,899,669 6.400% |
6,899,669 (New Position) |
Filing History |
| 2021-02-24 4:51 pm Purchase |
2021-02-23 | 13G | VPC Impact Acquisition Holdings VIH |
Point72 Asset Management, L.P. | 1,159,546 5.600% |
1,159,546 (New Position) |
Filing History |
| 2021-02-23 4:38 pm Purchase |
2021-02-22 | 13G | Chimerix, Inc. CMRX |
Point72 Asset Management, L.P. | 3,835,470 5.000% |
3,669,906 (+2216.61%) |
Filing History |
| 2021-02-16 3:34 pm Sale |
2020-12-31 | 13G | Vaccinex, Inc. VCNX |
Point72 Asset Management, L.P. | 0 0.000% |
-6,786 (Position Closed) |
Filing History |
| 2021-02-16 3:33 pm Sale |
2020-12-31 | 13G | BGC Partners, Inc. BGCP |
Point72 Asset Management, L.P. | 6,057,640 1.900% |
-9,471,320 (-60.99%) |
Filing History |
| 2021-02-16 3:32 pm Sale |
2020-12-31 | 13G | Calithera Biosciences, Inc. CALA |
Point72 Asset Management, L.P. | 86,718 2.500% |
-75,284 (-46.47%) |
Filing History |
| 2021-02-16 3:31 pm Sale |
2020-12-31 | 13G | Chiasma, Inc. CHMA |
Point72 Asset Management, L.P. | 1,266,112 2.200% |
-1,235,217 (-49.38%) |
Filing History |
| 2021-02-16 3:30 pm Sale |
2020-12-31 | 13G | IMMUNOMEDICS INC IMMU |
Point72 Asset Management, L.P. | 0 0.000% |
-10,954,266 (Position Closed) |
Filing History |
| 2021-02-16 3:30 pm Sale |
2020-12-31 | 13G | Otonomy, Inc. OTIC |
Point72 Asset Management, L.P. | 2,382,500 4.900% |
-526,997 (-18.11%) |
Filing |
| 2021-02-16 3:29 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Point72 Asset Management, L.P. | 550 0.100% |
-458,946 (-99.88%) |
Filing History |
| 2021-02-16 3:28 pm Purchase |
2020-12-31 | 13G | VYNE Therapeutics Inc. VYNE |
Point72 Asset Management, L.P. | 1,447 0.100% |
1,447 (New Position) |
Filing History |
| 2021-02-16 3:27 pm Sale |
2020-12-31 | 13G | American Eagle Outfitters, Inc. AEO |
Point72 Asset Management, L.P. | 2,206,963 1.300% |
-6,127,029 (-73.52%) |
Filing History |
| 2021-02-16 3:26 pm Sale |
2020-12-31 | 13G | Angi Inc. ANGI |
Point72 Asset Management, L.P. | 269,559 3.500% |
-109,024 (-28.80%) |
Filing History |